A. Ernest Toth Jr

Insider Reports History

Entity
Individual
Signature
/s/ Lori J. Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by A. Ernest Toth Jr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aquestive Therapeutics, Inc. SVP, Chief Financial Officer Common Stock 248K $1.21M $4.88 Mar 9, 2024 Direct
Aquestive Therapeutics, Inc. SVP, Chief Financial Officer Performance Stock Units 70K Aug 9, 2023 Direct
Aquestive Therapeutics, Inc. SVP, Chief Financial Officer Non-Qualified Stock Option (right to buy) 60K Mar 7, 2024 Direct

Insider Reports Filed by A. Ernest Toth Jr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AQST Aquestive Therapeutics, Inc. Mar 9, 2024 1 -$57.1K 4 Mar 12, 2024 SVP, Chief Financial Officer
AQST Aquestive Therapeutics, Inc. Mar 7, 2024 2 $0 4 Mar 11, 2024 SVP, Chief Financial Officer
AQST Aquestive Therapeutics, Inc. Aug 9, 2023 1 $0 4 Aug 9, 2023 SVP, Chief Financial Officer
AQST Aquestive Therapeutics, Inc. May 5, 2023 1 $0 4 May 5, 2023 SVP, Chief Financial Officer
AQST Aquestive Therapeutics, Inc. Mar 9, 2023 1 $0 4 Mar 9, 2023 SVP, Chief Financial Officer
AQST Aquestive Therapeutics, Inc. Nov 4, 2022 1 $0 4 Nov 8, 2022 SVP, Chief Financial Officer
AQST Aquestive Therapeutics, Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 Interim CFO
AQST Aquestive Therapeutics, Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 SVP, Chief Financial Officer